Arnout Schepers

Company: TenAces Biosciences

Job title: CEO

Seminars:

Panel Discussion: Moving from Phenotypic Screening to Target Based Discovery 8:50 am

• Overview of panellist’s platform technologies to identify glues and degraders including scientific or technical hurdles platforms address • How can we combat the diversity in compounds when rationally designing novel candidates? • What features define a protein as ligandable within a target space? • How can we provide systematic and scalable screening panels; the…Read more

day: Conference Day 2